ACQUISITION OF BENEFICIAL OWNERSHIP

Company

Autolus Therapeutics plc

Filed

December 13, 2022

Accession Number

0001387131-22-012374

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →